• ANITA CHAUDHARY Department of Pathology, Government Medical College, Patiala, Punjab, India.
  • Ninder Kumar Department of Pathology, Government Medical College, Patiala, Punjab, India.
  • RITU KUNDAL Department of Peadiatrics, Maharishi Markandeshwar Medical College, Solan, Himachal Pradesh, India.
  • RAMESH KUMAR Department of Pathology, Government Medical College, Patiala, Punjab, India.
  • PREET KAMAL SIBIA Department of Obstetrics and Gynaecology, Government Medical College, Patiala, Punjab, India.



Beta Thalassemia, Hemoglobinopathies, HbA2, HbF, HPLC


Objectives: The aim of the study was to study the incidence of thalassemia minor by determining HbA2 levels in pregnant females attending Obstetrics and Gynaecology OPD and HbA2 levels of husbands of positive females for beta-thalassemia trait.

Methods: The prospective study spanning over 1½ years was conducted in the Department of Pathology in 1020 pregnant females who attended the Gynaecology and Obstetrics OPD of Government Medical College, Patiala for antenatal check-up. The pregnant females of any trimester without any specific sign and symptoms whose Hb level was <10 g/dL were screened in the study. Levels of HbA2 and HbF were determined by high performance liquid chromatography (HPLC) and the cases with raised HbA2 value above the cutoff limit (>3.5%) were labeled as BTT. Husbands of BTT positive females were also screened for the trait. Incidence of all these cases was calculated and analyzed statistically.

Results: The majority of the females were in the age group of 21–30 years. In present study, we found that total 134 (13.1%) patients were having beta thalassemia trait. Husbands of all these positive patients were also screened for BTT and only 2 (1.49%) of them were found to be positive.

Conclusion: HPLC has the advantage for screening and detection of various hemoglobinopathies by providing rapid and accurate results. HPLC can detect and measure HbF and HbA2 in a single system. Early diagnosis and management of thalassemia can help in reduction of burden on society as well as government.


Download data is not yet available.


Bain BJ, Bates I, Laffan MA, Lewis SM, editors. Dacie and Lewis Practical Haematology. 12th ed. London: Churchill Livingstone; 2017.

Petrakos G, Andriopoulos P, Tsironi M. Pregnancy in women with thalassemia: Challenges and solutions. Int J Womens Health 2016;8:441-51. doi: 10.2147/IJWH.S89308, PMID 27660493

Pignatti CB, Galanello R. Thalassemias and related disorders. Quantitative Disorders of hemoglobin synthesis. Solutions. In: Wintrobe’s Clinical Hematology. 14th ed. Netherlands: Wolters Kluwer; 2019.

Modell B, Bulyzhenkov V. Distribution and control of some genetic disorders. World Health Stat Q 1988;41:209-18. PMID 3232409

Gu X, Zeng Y. A review of the molecular diagnosis of thalassemia. Hematology 2002;7:203-9. doi: 10.1080/1024533021000024102, PMID 14972782

Giambona A, Passarello C, Renda D, Maggio A. The significance of the hemoglobin A2 value in screening for hemoglobinopathies. Clin Biochem 2009;42:1786-96. doi: 10.1016/j.clinbiochem.2009.06.026, PMID 19591816

Kutlar F. Diagnostic approach to hemoglobinopathies. Hemoglobin 2007;31:243-50. doi: 10.1080/03630260701297071, PMID 17486507

Leung TY, Lao TT. Thalassaemia in pregnancy. Best Pract Res Clin Obstet Gynaecol 2012;26:37-51. doi: 10.1016/j.bpobgyn.2011.10.009, PMID 22079388

Baxi A, Manila K, Kadhi P, Heena B. Carrier screening for β thalassemia in pregnant Indian women: Experience at a single center in Madhya Pradesh. Indian J Hematol Blood Transfus 2013;29:71-4. doi: 10.1007/ s12288-012-0165-8, PMID 24426339

Shirlyn B, McKenzie IS, editors. Textbook of Hematology. 2nd ed. Philadelphia, PA: William and Wilkins; 1996. p. 1-9.

Whipple GH, Bradford WL. Mediterranean disease-thalassemia (erythroblastic anaemia of Cooley): Associated pigment abnormalities simulating hemochromatosis. J Pediatr 1936;9:279-311. doi: 10.1016/ S0022-3476(36)80021-3

Khadija, Arain SP, Alahmadi YM, Alolayan SO, Ahmer A, Ahmed T. Frequency of beta thalassemia in anemic pregnant women. JPRI 2021;33:1-5. doi: 10.9734/jpri/2021/v33i531175

Baliyan M, Kumar M, Nangia A, Parakh N. Can RBC indices be used as screening test for beta-thalassemia in Indian antenatal women? J Obstet Gynaecol India 2019;69:495-500. doi: 10.1007/s13224-019- 01220-8, PMID 31844363

Colah R, Gorakshakar A, Surve R, Wadia M, Ghosh K, Mohanty D. Feasibility of antenatal screening of beta-thalassemia in Mumbai, India. Acta Haematol 2001;105:252. doi: 10.1159/000046576, PMID 11528103

Mendiratta SL, Bajaj S, Popli S, Singh S. Screening of women in the antenatal period for thalassemia carrier status: Comparison of NESTROFT, red cell indices, and HPLC analysis. J Fetal Med 2015;2:21-5. doi: 10.1007/s40556-015-0036-0

Sinha PA, Mulkutkar SH, Bhavani JB. Study of distribution of ABO blood groups in ß-thalassemia patients. Int J Res Med Sci 2017;5:3479-83. doi: 10.18203/2320-6012.ijrms20173545

Balgir RS. Spectrum of hemoglobinopathies in the state of Orissa, India: A ten years cohort study. J Assoc Physicians India 2005;53:1021-6. PMID 16572956

Sachdev R, Dam AR, Tyagi G. Detection of Hb variants and hemoglobinopathies in Indian population using HPLC: Report of 2600 cases. Indian J Pathol Microbiol 2010;53:57-62. doi: 10.4103/0377-4929.59185, PMID 20090224

Mohanty D, Colah RB, Gorakshakar AC, Patel RZ, Master DC, Mahanta J, et al. Prevalence of β-thalassemia and other haemoglobinopathies in six cities in India: A multicentre study. J Community Genet 2013;4:33-42. doi: 10.1007/s12687-012-0114-0, PMID 23086467.

Bhukhanvala DS, Sorathiya SM, Sawant P, Colah R, Ghosh K, Gupte SC. Antenatal screening for identification of couples for prenatal diagnosis of severe hemoglobinopathies in Surat, South Gujarat. J Obstet Gynaecol India 2013;63:123-7. doi: 10.1007/s13224-012- 0271-4, PMID 24431619

Hanprasertpong T, Kor-anantakul O, Leetanaporn R, Suntharasaj T, Suwanrath C, Pruksanusak N, et al. Pregnancy outcomes amongst thalassemia traits. Arch Gynecol Obstet 2013;288:1051-4. doi: 10.1007/ s00404-013-2886-9, PMID 23681496

Kumar R, Gupta S, Jindal A, Kakkar S, Kaur A. Screening of beta thalassemia trait and other hemoglobinopathies among blood donors in Punjab. Int J Med Public Health 2015;5:1-4

Mondal SK, Mandal S. Prevalence of thalassemia and hemoglobinopathy in eastern India: A 10-year high-performance liquid chromatography study of 119,336 cases. Asian J Transfus Sci 2016;10:105-10. doi: 10.4103/0973-6247.175424, PMID 27011683

Konar (Sanyal) K, Karmakar A, Mondal B. Clinico-hematological pattern of thalassemias and hemoglobinopathies in children presenting with microcytic anaemia: An outdoor-based study at Burdwan, West Bengal. Int J Curr Res Rev 2018;10:27-34. doi: 10.31782/ IJCRR.2018.10104

Saxena S, Jain R. Evaluation of the diagnostic reliability of mentzer index for beta thalassemia trait followed by HPLC. Trop J Pathol Microbiol 2020;6:124-9. doi: 10.17511/jopm.2020.i02.03

Dolai TK, Dutta S, Bhattacharyya M, Ghosh MK. Prevalence of hemoglobinopathies in rural Bengal, India. Hemoglobin 2012;36:57-63. doi: 10.3109/03630269.2011.621007, PMID 22004064



How to Cite

ANITA CHAUDHARY, Ninder Kumar, RITU KUNDAL, RAMESH KUMAR, and PREET KAMAL SIBIA. “THE INCIDENCE OF BETA-THALASSEMIA MINOR IN PREGNANT FEMALES BY MEASURING HBA2 THROUGH HIGH PERFORMANCE LIQUID CHROMATOGRAPHY”. Asian Journal of Pharmaceutical and Clinical Research, vol. 15, no. 7, July 2022, pp. 81-86, doi:10.22159/ajpcr.2022.v15i7.44840.



Original Article(s)